Study on the correlation between the concentration of plasma lipoprotein-associated phospholipase A2 and coronary

Jin-Ming Cen1, Jie Cheng2, Qing-Yuan Xiong3

  • 1Department of Cardiology, Foshan Municipal First People's Hospital, Foshan, Guangdong 528000, China.

Insights

Plasma lipoprotein-associated phospholipase A2 (Lp-PLA2) levels are elevated in coronary heart disease (CHD) patients. Higher Lp-PLA2 concentrations correlate with increased CHD severity and may synergize with hs-CRP in atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Inflammation Research

Background:

  • Coronary heart disease (CHD) remains a leading cause of mortality worldwide.
  • Lipoprotein-associated phospholipase A2 (Lp-PLA2) is implicated in atherosclerotic plaque development.
  • Understanding biomarkers for CHD severity is crucial for risk stratification.

Purpose of the Study:

  • To investigate the correlation between plasma Lp-PLA2 levels and coronary heart disease (CHD).
  • To compare plasma Lp-PLA2 concentrations across different CHD subtypes.
  • To explore the relationship between Lp-PLA2 and other cardiovascular risk factors.

Main Methods:

  • Blood samples were collected from 56 CHD patients and 34 healthy controls.
  • Plasma Lp-PLA2 concentrations were measured.
  • Levels of total cholesterol, triglycerides, apolipoproteins, HDL-c, LDL-c, Lp(a), glucose, and hs-CRP were determined.

Main Results:

  • Plasma Lp-PLA2 was significantly higher in all CHD subgroups compared to controls (P < 0.05).
  • Lp-PLA2 levels were highest in acute myocardial infarction (AMI) patients, followed by unstable angina pectoris (UAP), and then stable angina pectoris (SAP) (P < 0.05).
  • Plasma Lp-PLA2 showed a positive correlation with high-sensitivity C-reactive protein (hs-CRP) (r = 0.493, P < 0.05) but not with other tested lipid parameters.

Conclusions:

  • Elevated plasma Lp-PLA2 is associated with CHD.
  • Plasma Lp-PLA2 concentrations vary significantly across different CHD severity levels.
  • Synergistic action between Lp-PLA2 and hs-CRP may contribute to the inflammatory response in atherosclerosis.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
656
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
646
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
741
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
426